ZNTL — Zentalis Pharmaceuticals Llc · $257.7M cap

Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.

Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.

Use this ZNTL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ZNTL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ZNTL SEC filings page. Lician reads the product cache first so this HTML stays unique to Zentalis Pharmaceuticals Llc even when a live quote feed is slow.

Zentalis Pharmaceuticals Llc latest statements (FY2025)

Latest cached year on this hub. Full ZNTL income, balance, and cash tables.

  • Revenue$0
  • Net Income-$137.1M
  • Total Assets$289.0M
  • Total Debt$0
  • Free Cash Flow-$125.2M

ZNTL recent filings